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Structured Abstract 
Many physiological and cellular processes cycle with time, with the period between one 
peak and the next being roughly equal to 24 hours.  These circadian rhythms underlie 
“permissive homeostasis”, whereby anticipation of periods of increased energy demand or 
stress may enhance the function of individual cells, organ systems or whole organisms.  
Many physiological variables related to survival during critical illness have a circadian 
rhythm, including the sleep/wake cycle, haemodynamic and respiratory indices, immunity 
and coagulation, but their clinical significance remains underappreciated.  Critically ill 
patients suffer from circadian dysrhythmia, manifesting overtly as sleep disturbance and 
delirium, but with widespread covert effects on cellular and organ function.  Environmental 
and pharmacological strategies that ameliorate or prevent circadian dysrhythmia have 
demonstrated clinical benefit.  Harnessing these important biological phenomena to match 
metabolic supply to demand and bolster cell defenses at the apposite time may be a future 
therapeutic strategy in the intensive care unit. 
“Rhythms of life” 
The earth completes one rotation on its axis every 24 hours, exposing its surface inhabitants 
to predictable periods of light and darkness. This influences the temporal organisation of 
behaviour, such as physical activity, feeding and sleeping, each of which imposes specific 
demands on cells and physiological systems, such as exposure to pathogens, oxidative stress 
or surges in energy requirements.  Diverse biological processes, from global haemodynamics 
to intracellular protein levels – even the composition of the microbiome (1) – also 
demonstrate distinct temporal oscillations with a period of approximately 24 hours between 
one peak to the next (2).  These cycles are termed circadian rhythms, and have been 
observed in almost every living creature on Earth (3).  They support “predictive 
homeostasis” by upregulating metabolic capacity and self-defense mechanisms in 
anticipation of periods of increased demand.  In critical illness, where support of 
physiological processes stands between life and death, there is a pressing need to 
understand the biological significance of these rhythms and how to circumvent the negative 
consequences of their disruption. 
 
Molecular basis of circadian rhythms  
Circadian rhythmicity has been demonstrated in physiological indices (core body 
temperature, brain wave activity, cardiovascular and respiratory function, coagulation and 
immunity) (4) and intracellular processes (mitochondrial metabolism, protein expression, 
enzyme activity, redox cycles, DNA repair and cell regeneration) (5) (6).  Rhythmicity is 
generated at the level of the individual cell by a complex series of positive and negative 
feedback loops, controlled by a set of circadian transcription factors, 10 of which have been 
identified so far, including: CLOCK, PERIOD (1-3), CRY (1-2) and BMAL1 (7).  It is estimated 
that one third of all gene activity is regulated by this intracellular “clock” (8).  
Polymorphisms in clock genes determine important phenotypes, such sleeping behaviour, 
which varies between individuals across a spectrum from “morningness” (early birds) to 
“eveningness” (night owls) (9). Such chronotypes also appear to influence the time of peak 
performance in athletes (10), and may even determine the most likely hour of death (9). 
 
Entrainment and synchronisation of many clocks 
 
Whilst every cell has rhythms driven by its own “clock”, in humans a central pacemaker 
located in the suprachiasmatic nucleus (SCN) of the hypothalamus co-ordinates the clocks in 
many diverse tissues through neural and hormonal pathways (11). The SCN controls the 
secretion of the chief circadian hormone, melatonin, through sympathetic projections to the 
pineal gland.  During a typical light/dark cycle, pineal melatonin secretion begins between 9-
11 pm, reaches a peak between 1-3 am and falls to baseline again between 7-9 am (12, 13).  
Melatonin acts at cell receptors in the central nervous system, regulating the sleep/wake 
cycle, and in peripheral tissues, stabilizing circadian rhythms and aligning the phase 
relationships of peripheral clocks (11). Through projections to other hypothalamic centres, 
the SCN also drives circadian fluctuation in sympathetic and parasympathetic tone, and the 
release of cortisol and growth hormone (14).  Circadian rhythms persist in the absence of 
external stimuli, but they may be modulated over time by external cues, or “Zeitgebers 
(“time givers”), the most important of which is light (15). It was recently discovered that a 
third type of photoreceptor, the retinal ganglion cell, projects non-visual light information to 
the SCN, tuning the central pacemaker to seasonal changes in the light/dark cycle 
(entrainment) (16).  Other “Zeitgebers” capable of resetting the clock include ambient 
temperature, feeding and social interaction (17). 
Circadian rhythms in the intensive care unit 
 
The chief tenet of intensive care medicine is the support of organ function and cell viability 
during episodes of severe pathophysiological stress.  Physiological indices are measured 
continuously, and interventions undertaken to maintain them within the ranges observed in 
health.  However, the function of various systems, including the autonomic nervous system, 
solid organs, coagulation and immune systems, display circadian rhythmicity (4) 
(summarised in Figure 1).  Familiarity with “normal” patterns of variation in haemodynamic 
indices over 24 hours would assist clinicians in distinguishing these natural fluctuations 
(illustrated schematically in Figure 2) from a change in the patient’s clinical status.  Cycles of 
activity place patients at differential risk of adverse events at different times of day.  
Nocturnal decrease in blood pressure increases the risk of haemodynamic compromise, 
particularly in shocked patients, or those with coronary insufficiency.  The morning triad of 
rising heart rate, persistently high systemic vascular resistance and peak in platelet 
aggregability could explain the 3-fold increase in incidence of myocardial ischaemia 
observed between the hours of 6 am and noon (18).  Pharmacologically blunting circadian 
peaks in heart rate and haemostasis with beta-blockers and aspirin alters this pattern of 
morbidity and mortality (19, 20).  Respiratory function, from lung mechanics to the 
secretion of surfactant, have circadian rhythms, with surfactant nadir at 10 pm and peak 12 
hours later, theoretically influencing susceptibility to acute lung injury (21).  Targeted 
monitoring and intervention could reduce the harm associated with periods of heightened 
“chronorisk”.  
 
Circadian variation in the systems we cannot visualise on a bedside monitor may be just as 
influential.  Cycles in liver and kidney function markedly influence the metabolism and 
excretion of many drugs, generating significant variation in circulating drug concentrations, 
according to the time of administration (22).  Chronopharmacology is an emerging field 
dedicated to optimising the timing of drug delivery to enhance efficacy and minimize 
toxicity, through improved understanding of circadian pharmacokinetics and 
pharmacodynamics (23).  This is particularly important for drugs with a narrow therapeutic 
index and significant circadian fluctuation, many of which are in common use in the 
intensive care unit, including antibiotics, steroids, anticoagulants and antihypertensives (24) 
(25) (26).  Immune function ebbs and flows over a 24 hour period, as demonstrated by 
levels of circulating immune cells and cytokines and expression of pattern recognition 
molecules (27) (2).  The clinical manifestations of rheumatoid arthritis follow the pattern of 
interleukin-6 expression, peaking in the morning, and mortality rates following 
administration of endotoxin depend upon the time of exposure (28). 
 
The amplitude of circadian variation (the difference between the peak and trough) itself 
appears to play an important physiological function, and has been proposed to represent 
capacity for adaptation.  In health, resting heart rate varies between 5 to 25 beats per 
minute, and decreased heart rate variability is a poor prognostic factor in critical illness (29, 
30).  The nocturnal dip in blood pressure observed in healthy subjects appears to be 
protective, as patients with hypertension or autonomic neuropathy, in whom this circadian 
trough is diminished or abolished, suffer a greater degree of end-organ damage than those 
in whom it is preserved (31).  There is, as yet, no evidence base for deliberately emulating 
circadian rhythms of physiological indices on the intensive care unit, but this concept 
deserves further thought and investigation. 
 
Critical illness causes circadian dysrhythmia 
 
Circadian rhythms in critically ill patients are severely disrupted, with alterations in the 
normal 24 hour pattern of melatonin and cortisol secretion, brain wave and spontaneous 
motor activity, blood pressure, heart rate and core temperature (32).  Circadian 
dysrhythmia involves a change in one or more of the aspects of the morphology of a normal 
cycle (illustrated in Figure 2). This may be a change in amplitude (exaggeration or flattening 
of the normal degree of fluctuation from the mean, Figure 4), a phase shift (such that peak 
function or “acrophase” no longer occurs at the usual time of day, Figure 5), or 
disintegration of a defined cycle into a chaotic pattern (33) (Figure 6).  It may also describe 
an uncoupling of one or more peripheral rhythms from either the central pacemaker or 
from each other (34).  Critical illness circadian dysrhythmia often takes the form of 
decreased amplitude and phase delay, with progressive degradation over time to erratic 
fluctuation or complete flattening (4).  In health, core temperature has one of the most 
stable rhythms, with nadir consistently around 5 am, but in chronic critical illness, nadir 
becomes widely dispersed throughout day or night, and variation between peaks and 
troughs diminishes (35). Loss of amplitude may impair the capacity for adaptation, while 
phase shifts uncouple maximum function from peak demand.  Severity of illness has been 
shown to correlate with degree of circadian disruption (36). 
 
Aetiology of circadian dysrhythmia on the intensive care unit  
 
Circadian dysrhythmia in the intensive care unit results from both environmental and 
internal disturbance. There is loss of distinction between day and night, with the greatest 
light intensity in an average intensive care unit 10 to 50 times less than that outdoors on 
even an overcast day (and up to 1000 times less than a sunny day) (37) (38). Continuous 
glare from monitors and side lights also diminishes nocturnal darkness. Entrainment by 
alternative “Zeitgebers” is also lost, with daytime meals, physical activity and social 
interactions replaced with continuous feeding regimes, bed rest and sedation.  Feeding mice 
according to a reversed schedule (during sleep rather than active phase), uncouples their 
liver circadian rhythms from the master pacemaker, and results in higher mortality rates on 
subsequent induction of sepsis (39).  Systemic inflammation also interferes with circadian 
rhythms.  The rhythm of the urinary metabolite of melatonin has diminished amplitude and 
delayed acrophase in septic patients compared to non-septic critically ill patients (34).  This 
effect appears to be mediated by decreased clock gene expression (CRY1 and PER2), in the 
presence of high levels of circulating cytokines (IL-6 and TNF alpha), and can be induced by 
infusion of endotoxin in healthy humans (40). Peripheral secretion of melatonin by 
macrophages, in response to inflammation, generates high local concentrations (millimolar), 
which drown out the subtle fluctuations (nanomolar to picomolar) from the pineal gland, 
such that central communication with peripheral clocks is lost in inflammatory states (41).  
In this context melatonin appears to have a secondary function as an immunomodulator 
(enhancing phagocytosis initially, and later inducing production of anti-inflammatory 
cytokines) (42)  The uncoupling of peripheral clocks from the master pacemaker has been 
proposed to play a role in the pathogenesis of multiple organ failure (43). Impairments in 
liver and kidney function will alter metabolism and secretion of melatonin, while opiates 
and benzodiazepines enhance its day-time production in a dose-dependent manner, 
through induction of a key enzyme in its biosynthetic pathway (44) (45).  Pineal secretion 
will be stimulated by beta-receptor agonists and endogenous catecholamines (32).  Other 
intensive care interventions, even oxygen itself, may contribute to circadian dysrhythmia, 
with hyperoxia shown to disrupt circadian gene expression and proposed to contribute to 
the development of acute lung injury (46).  Melatonin secretion appears to be lower during 
periods of mechanical ventilation (47), and of all the ventilation modes, pressure support 
results in the greatest degree of sleep disturbance (48). 
 
Ramifications of Circadian Dysrhythmia 
 
“Jet lag” denotes the overt symptoms of circadian disruption, but we now know that effects 
extend deeper, impairing physiological and cellular processes.  Functional impairment is 
mediated through anomalies of clock gene expression and the downstream effects on the 
multiple other genes whose expression they control. For example, alternating light and dark 
exposure every 10 hours (rather than every 12) decreases levels of BMAL1 and PER2, and 
subsequently downregulates target genes which include those crucial to hypertrophic 
remodeling (49). This manifests clinically as impaired compensation in a mouse model of 
pressure overload cardiomyopathy (50). Circadian dysrhythmia has been implicated in the 
pathogenesis of cardiac arrhythmias and sudden cardiac death (51).  Disturbance in renal 
circadian rhythms is a risk factor for hypertension, polyuria and fibrosis (52) (53).  Simulated 
jet lag increases the rate of tumour progression in mice (54) (55), corresponding to the 
increased risk of breast cancer in shift workers (56).  Altered circadian expression of a major 
regulator of fibrinolysis appears to influence susceptibility to myocardial infarction (57).  
Circadian dysrhythmia alters metabolic function, with derangements in lipid and glucose 
homeostasis leading to obesity and glucose intolerance (58). A mutation in one clock gene 
triggers a metabolic switch towards fatty acid oxidation and increased myocardial oxygen 
consumption, inhibiting the ability of cells to meet metabolic demands under stress 
conditions (5). Immunity could also be weakened by disruption of the circadian patterns 
required for the temporal organisation of its many different steps (59).  Reduction of heart 
rate variability is a poor prognostic sign in critically ill patients, correlating with severity of 
organ dysfunction and predicting ability to wean from mechanical ventilation (29) (30). 
Finally, the most visible corollaries of circadian dysrhythmia on the intensive care unit are 
sleep fragmentation and delirium.  Polysomnography in critically ill patients reveals severe 
disruption in brain wave circadian rhythms, with loss of slow wave and rapid eye movement 
(REM) sleep, a shift towards light sleep, or complete abolition of the recognisable stages of 
sleep and wakefulness (60).  There is a complex relationship between circadian dysrhythmia, 
sleep disturbance and delirium, with delirium suggested to be the visible embodiment of 
circadian dysrhythmia.  Delirium occurs in up to 80% of critically ill patients and is associated 
with striking increases in morbidity and mortality (61).  Any of these circadian dysrhythmias 
has the potential to threaten survival in critical illness. Disrupting circadian rhythms in septic 
mice increases their mortality rates and severity of illness has been shown to correlate with 
degree of circadian disruption (36) (62).  
 
Chronotherapy 
 
In animal models of circadian dysrhythmia-induced pathology, restoration of normal 
circadian rhythms attenuates or reverses symptoms (49). Proposed chronotherapies in 
intensive care include re-entrainment with bright light or restoration of dark periods, and 
pharmacological intervention with night-time administration of melatonin or its agonists 
(ramelteon) (63). 
 
Light is the most potent cue for the entrainment of circadian rhythms and may boost 
flagging circadian rhythms in patients. Lower mortality rates (7% compared to 12%) and 
shorter lengths of stay have been reported in brighter intensive care rooms (average 
intensity 1000 – 2500 lux compared to <400 lux) (64).  Lack of visible daylight is a risk factor 
for developing delirium, while windows appear to be protective (65) (66).  Several 
randomized control trials (RCTs) have demonstrated that morning light exposure in acutely 
ill patients reduces delirium prevalence (from 40 - 42 % in controls to 0 - 16% in the light 
therapy groups) and duration (63). The impact of light therapy on other sequelae of 
circadian dysrhythmia, such as autonomic, cardiovascular, metabolic or immune 
dysfunction, remains largely unexplored in this cohort, but as targets they may prove to be 
equally relevant.  The optimum timing, intensity, wavelength and duration of light exposure 
is yet to be defined (67), with the SCN in septic patients less sensitive to light than in health 
(68).  With evidence accumulating for marked clinical benefit from a strategy as non-
invasive and inexpensive as light, monitoring light intensity on the intensive care unit and 
setting morning targets constitutes a simple standard of care.  Other environmental 
strategies to entrain circadian rhythms include minimisation of noise and sleep interruption, 
and early mobilisation.  In animal models, restricting feeding to the active phase amplifies 
circadian rhythms and improve metabolic disorders (69) (70).  Abandoning 24 hour 
continuous feeding regimes, particularly during the night, and investing in chrononutritional 
research will be an important aspect of the multi-modal environmental approach to treating 
circadian dysrhythmia. 
 
The pharmacological strategy for enhancing circadian rhythmicity has so far focused on 
night-time administration of melatonin or its agonists. Several RCTs have demonstrated 
their effectiveness in reducing delirium rates: in the post-operative period (71), in medical 
inpatients (72) and in the intensive  care setting (73) – with incidence two to four times 
lower in the treatment groups compared to controls. Doses of up to 10 mg of melatonin 
were not associated with any ill effects, and in several studies the time of administration 
was as early as 6 to 8 pm (63).  Melatonin may exert beneficial effects during critical illness 
through several pathways, dampening the hyperinflammatory response during sepsis in 
neonates and animal models and demonstrating in vitro antimicrobial activity against multi-
drug resistant bacteria (74).  The discovery that melatonin is produced within every cell 
capable of oxidative phosphorylation highlights its vital role as an antioxidant (75).  It 
defends against oxidative damage by scavenging reactive oxygen and nitrogen species and 
promoting the activities of antioxidant enzymes.  Its activity has been shown to protect 
kidney grafts and gut mucosa from the harmful effects of ischaemia reperfusion injury, and 
thus demonstrates potential in combating the oxidative stress compounding critical illness 
(76).  
 
Future chronotherapies may need to take account of the genetically-determined differences 
in circadian phenotypes (chronotypes) between individuals. Clock gene polymorphisms 
linked to different sleep/wake patterns are likely to influence the timing of the whole gamut 
of systems under circadian control  (77). There may be a role for personalised medicine in 
enhancing the efficacy of chronotherapy, with prior knowledge of an individual’s genetic 
and phenotypic circadian profile informing decisions about the optimum dose or timing of 
chronotherapies.  
 Future directions 
 
With 24 hour continuous monitoring, intensive care units are an opportune setting for 
chronobiological surveillance, to characterise periods of increased risk and to administer 
medications or interventions at times most conducive to achieving their desired effect. 
Collaboration between physicians, scientists and mathematicians will be required to 
navigate this field, to combine computational analysis of vast time-series data sets (“big 
data”) with molecular processes and clinical outcomes.  Knowledge of circadian cycles 
involved in immunity and haemostasis may allow us to schedule surgery at favourable 
times, a so-called “rhythm strategy” already utilised in the administration of chemotherapy 
(78).  Chronobiological interventions have shown promise in improving clinical outcomes 
through amelioration of delirium and sleep disturbance, but further work is required to 
determine their effectiveness in combating the covert dysfunction in other organ systems 
associated with circadian dysrhythmias. 
Conclusions 
 
Circadian dysrhythmia should be recognised as a pathological syndrome that has a 
significant impact on the outcome of critically ill patients (79), but also the clinical staff who 
take care of them.  The overt symptoms of circadian dysrhythmia, such as sleep disturbance, 
inattention and dysphoria, challenge the work performance and mental health of shift 
workers in the intensive care unit, with long-term health consequences ranging from 
metabolic dysfunction to cancer (80).  Intensive care physicians are dedicated to identifying 
and treating physiological disturbances, but the monitoring and restoration of circadian 
rhythms has not yet been introduced to clinical practice.  In the future, various indices, from 
serum melatonin to heart rate variability to core temperature, may be used as biomarkers 
to diagnose circadian disturbance, and may one day represent key therapeutic targets.  
 
Key points: 
 
1. Circadian rhythms synchronise biological function with anticipated demand. 
2. Circadian dysrhythmia is a common affliction in the intensive care unit, both in 
patients and in staff. 
3. Circadian dysrhythmia directly contributes to disease, and will exacerbate cell and 
organ dysfunction in critical illness, creating a vicious circle. 
4. Morning bright light is a harmless and powerful way of bolstering failing circadian 
rhythms. 
5. Melatonin may improve outcomes in critical illness through its chronobiological, 
anti-inflammatory, antimicrobial and antioxidant properties. 
 
 
Abbreviations 
BMAL1: Brain and Muscle ARNT-Like 1 
CLOCK: Circadian Locomotor Output Cycles Kaput 
CRY (1-2): Cryptochrome circadian clock (1-2) 
DNA: Deoxyribonucleic acid 
IL-6: Interleukin 6 
PER (1-3): Period circadian clock (1-3) 
RCT: randomised controlled trial 
REM: rapid eye movement 
SCN: Suprachiasmatic nucleus 
TNF alpha: Tumour Necrosis Factor alpha 
 
Acknowledgements 
HM thanks the London Clinic for its support. 
 
Declaration of conflicting interests 
None declared. 
 
Funding acknowledgement 
This research received no specific grant from any funding agency. 
 
1. Thaiss CA, Levy M, Korem T et al. Microbiota Diurnal Rhythmicity Programs Host 
Transcriptome Oscillations. Cell. 2016;167:1495-1510.e12. 
2. Esquifino AI, Cano P, Jiménez-Ortega V, Fernández-Mateos P, Cardinali DP. 
Neuroendocrine-immune correlates of circadian physiology: studies in experimental 
models of arthritis, ethanol feeding, aging, social isolation, and calorie restriction. 
Endocrine. 2007;32:1-19. 
3. Dunlap JC. Molecular bases for circadian clocks. Cell. 1999;96:271-290. 
4. Chan MC, Spieth PM, Quinn K, Parotto M, Zhang H, Slutsky AS. Circadian rhythms: 
from basic mechanisms to the intensive care unit. Crit Care Med. 2012;40:246-253. 
5. Bray MS, Shaw CA, Moore MW et al. Disruption of the circadian clock within the 
cardiomyocyte influences myocardial contractile function, metabolism, and gene 
expression. Am J Physiol Heart Circ Physiol. 2008;294:H1036-47. 
6. Peek CB, Affinati AH, Ramsey KM et al. Circadian clock NAD+ cycle drives 
mitochondrial oxidative metabolism in mice. Science. 2013;342:1243417. 
7. Kusanagi H, Hida A, Satoh K et al. Expression profiles of 10 circadian clock genes in 
human peripheral blood mononuclear cells. Neurosci Res. 2008;61:136-142. 
8. Bozek K, Relógio A, Kielbasa SM et al. Regulation of clock-controlled genes in 
mammals. PLoS One. 2009;4:e4882. 
9. Lim AS, Chang AM, Shulman JM et al. A common polymorphism near PER1 and the 
timing of human behavioral rhythms. Ann Neurol. 2012;72:324-334. 
10. Facer-Childs E, Brandstaetter R. The impact of circadian phenotype and time since 
awakening on diurnal performance in athletes. Curr Biol. 2015;25:518-522. 
11. Golombek DA, Rosenstein RE. Physiology of circadian entrainment. Physiol Rev. 
2010;90:1063-1102. 
12. Pevet P, Challet E. Melatonin: both master clock output and internal time-giver in the 
circadian clocks network. J Physiol Paris. 2011;105:170-182. 
13. Brzezinski A. Melatonin in humans. N Engl J Med. 1997;336:186-195. 
14. Buijs RM, la Fleur SE, Wortel J et al. The suprachiasmatic nucleus balances 
sympathetic and parasympathetic output to peripheral organs through separate 
preautonomic neurons. J Comp Neurol. 2003;464:36-48. 
15. Roenneberg T, Kumar CJ, Merrow M. The human circadian clock entrains to sun 
time.[letter]. Curr Biol 2007;17(2):R44-5. 
16. Brainard GC, Hanifin JP, Greeson JM et al. Action spectrum for melatonin regulation in 
humans: evidence for a novel circadian photoreceptor. J Neurosci. 2001;21:6405-6412. 
17. Hastings MH, Duffield GE, Ebling FJ, Kidd A, Maywood ES, Schurov I. Non-photic 
signalling in the suprachiasmatic nucleus. Biol Cell. 1997;89:495-503. 
18. Khan MS, Ahmad SI. Circadian variation--increased morning incidence of acute 
myocardial infarction in patients with coronary artery disease. J Pak Med Assoc. 
2003;53:84-87. 
19. Manfredini R, Boari B, Salmi R et al. Twenty-four-hour patterns in occurrence and 
pathophysiology of acute cardiovascular events and ischemic heart disease. Chronobiol 
Int. 2013;30:6-16. 
20. Ridker PM, Manson JE, Buring JE, Muller JE, Hennekens CH. Circadian variation of 
acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of 
physicians. Circulation. 1990;82:897-902. 
21. Mortola JP. Breathing around the clock: an overview of the circadian pattern of 
respiration. Eur J Appl Physiol. 2004;91:119-129. 
22. Beauchamp D, Labrecque G. Chronobiology and chronotoxicology of antibiotics and 
aminoglycosides. Adv Drug Deliv Rev. 2007;59:896-903. 
23. Dallmann R, Brown SA, Gachon F. Chronopharmacology: new insights and therapeutic 
implications. Annu Rev Pharmacol Toxicol. 2014;54:339-361. 
24. Beauchamp D, Labrecque G. Chronobiology and chronotoxicology of antibiotics and 
aminoglycosides. Adv Drug Deliv Rev. 2007;59:896-903. 
25. Schved JF, Gris JC, Eledjam JJ. Circadian changes in anticoagulant effect of heparin 
infused at a constant rate.[letter]. Br Med J (Clin Res Ed) 1985;290(6477):1286. 
26. Hermida RC, Ayala DE, Mojón A, Fernández JR. Influence of circadian time of 
hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol 
Int. 2010;27:1629-1651. 
27. Dengler V, Westphalen K, Koeppen M. Disruption of Circadian Rhythms and Sleep in 
Critical Illness and its Impact on Innate Immunity. Curr Pharm Des. 2015;21:3469-
3476. 
28. HALBERG F, JOHNSON EA, BROWN BW, BITTNER JJ. Susceptibility rhythm to E. 
coli endotoxin and bioassay. Proc Soc Exp Biol Med. 1960;103:142-144. 
29. Buchman TG, Stein PK, Goldstein B. Heart rate variability in critical illness and critical 
care. Curr Opin Crit Care. 2002;8:311-315. 
30. Huang CT, Tsai YJ, Lin JW, Ruan SY, Wu HD, Yu CJ. Application of heart-rate 
variability in patients undergoing weaning from mechanical ventilation. Crit Care. 
2014;18:R21. 
31. Ueda Y, Aoi W, Yamachika S, Nagataki S. Loss of nocturnal decline in blood pressure 
in diabetic patients with autonomic neuropathy. Jpn Heart J. 1992;33:801-815. 
32. Paul T, Lemmer B. Disturbance of circadian rhythms in analgosedated intensive care 
unit patients with and without craniocerebral injury. Chronobiol Int. 2007;24:45-61. 
33. Papaioannou V, Mebazaa A, Plaud B, Legrand M. Chronomics’ in ICU: circadian 
aspects of immune response and therapeutic perspectives in the critically ill. Intensive 
Care Med Exp. 2014;2:18. 
34. Li CX, Liang DD, Xie GH et al. Altered melatonin secretion and circadian gene 
expression with increased proinflammatory cytokine expression in early-stage sepsis 
patients. Mol Med Rep. 2013;7:1117-1122. 
35. Tweedie IE, Bell CF, Clegg A, Campbell IT, Minors DS, Waterhouse JM. 
Retrospective study of temperature rhythms of intensive care patients. Crit Care Med. 
1989;17:1159-1165. 
36. Gazendam JA, Van Dongen HP, Grant DA, Freedman NS, Zwaveling JH, Schwab RJ. 
Altered circadian rhythmicity in patients in the ICU. Chest. 2013;144:483-489. 
37. Verceles AC, Silhan L, Terrin M, Netzer G, Shanholtz C, Scharf SM. Circadian rhythm 
disruption in severe sepsis: the effect of ambient light on urinary 6-sulfatoxymelatonin 
secretion. Intensive Care Med. 2012;38:804-810. 
38. Turner PL, Van Someren EJ, Mainster MA. The role of environmental light in sleep 
and health: effects of ocular aging and cataract surgery. Sleep Med Rev. 2010;14:269-
280. 
39. Oyama Y, Iwasaka H, Koga H, Shingu C, Matsumoto S, Noguchi T. Uncoupling of 
peripheral and master clock gene rhythms by reversed feeding leads to an exacerbated 
inflammatory response after polymicrobial sepsis in mice. Shock. 2014;41:214-221. 
40. Haimovich B, Calvano J, Haimovich AD, Calvano SE, Coyle SM, Lowry SF. In vivo 
endotoxin synchronizes and suppresses clock gene expression in human peripheral 
blood leukocytes. Crit Care Med. 2010;38:751-758. 
41. Pontes GN, Cardoso EC, Carneiro-Sampaio MM, Markus RP. Injury switches 
melatonin production source from endocrine (pineal) to paracrine (phagocytes) - 
melatonin in human colostrum and colostrum phagocytes. J Pineal Res. 2006;41:136-
141. 
42. Carrillo-Vico A, Lardone PJ, Alvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero 
JM. Melatonin: buffering the immune system. Int J Mol Sci. 2013;14:8638-8683. 
43. Godin PJ, Buchman TG. Uncoupling of biological oscillators: a complementary 
hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit 
Care Med. 1996;24:1107-1116. 
44. Esposti D, Esposti G, Lissoni P, Parravicini L, Fraschini F. Action of morphine on 
melatonin release in the rat. J Pineal Res. 1988;5:35-39. 
45. Morera AL, Abreu-Gonzalez P, Henry M. Zaleplon increases nocturnal melatonin 
secretion in humans. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1013-1016. 
46. Czachor A, Krueger Z, Cho Y et al. Disruption of Circadian Rhythms in Critical Illness 
- A Role of Hyperoxia-Induced Lung Injury. Curr Pharm Des. 2015;21:3489-3495. 
47. Frisk U, Olsson J, Nylén P, Hahn RG. Low melatonin excretion during mechanical 
ventilation in the intensive care unit. Clin Sci (Lond). 2004;107:47-53. 
48. Boyko Y, Ording H, Jennum P. Sleep disturbances in critically ill patients in ICU: how 
much do we know. Acta Anaesthesiol Scand. 2012;56:950-958. 
49. Martino TA, Tata N, Belsham DD et al. Disturbed diurnal rhythm alters gene 
expression and exacerbates cardiovascular disease with rescue by resynchronization. 
Hypertension. 2007;49:1104-1113. 
50. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular 
consequences of circadian misalignment. Proc Natl Acad Sci U S A. 2009;106:4453-
4458. 
51. Jeyaraj D, Haldar SM, Wan X et al. Circadian rhythms govern cardiac repolarization 
and arrhythmogenesis. Nature. 2012;483:96-99. 
52. Koch BC, Nagtegaal JE, Kerkhof GA, ter Wee PM. Circadian sleep-wake rhythm 
disturbances in end-stage renal disease. Nat Rev Nephrol. 2009;5:407-416. 
53. Bonny O, Firsov D. Circadian regulation of renal function and potential role in 
hypertension. Curr Opin Nephrol Hypertens. 2013;22:439-444. 
54. Filipski E, Delaunay F, King VM et al. Effects of chronic jet lag on tumor progression 
in mice. Cancer Res. 2004;64:7879-7885. 
55. Van Dycke KC, Rodenburg W, van Oostrom CT et al. Chronically Alternating Light 
Cycles Increase Breast Cancer Risk in Mice. Curr Biol. 2015;25:1932-1937. 
56. He C, Anand ST, Ebell MH, Vena JE, Robb SW. Circadian disrupting exposures and 
breast cancer risk: a meta-analysis. Int Arch Occup Environ Health. 2015;88:533-547. 
57. Oishi K, Uchida D, Ohkura N et al. Ketogenic diet disrupts the circadian clock and 
increases hypofibrinolytic risk by inducing expression of plasminogen activator 
inhibitor-1. Arterioscler Thromb Vasc Biol. 2009;29:1571-1577. 
58. Garaulet M, Gómez-Abellán P. Chronobiology and obesity. Nutr Hosp. 2013;28 Suppl 
5:114-120. 
59. Dimitrov S, Lange T, Tieken S, Fehm HL, Born J. Sleep associated regulation of T 
helper 1/T helper 2 cytokine balance in humans. Brain Behav Immun. 2004;18:341-348. 
60. Gehlbach BK, Chapotot F, Leproult R et al. Temporal disorganization of circadian 
rhythmicity and sleep-wake regulation in mechanically ventilated patients receiving 
continuous intravenous sedation. Sleep. 2012;35:1105-1114. 
61. Scott BK. Disruption of Circadian Rhythms and Sleep in Critical Illness and its Impact 
on the Development of Delirium. Curr Pharm Des. 2015;21:3443-3452. 
62. Perras B, Kurowski V, Dodt C. Nocturnal melatonin concentration is correlated with 
illness severity in patients with septic disease.[letter]. Intensive Care Med 
2006;32(4):624-625. 
63. Oldham MA, Lee HB, Desan PH. Circadian Rhythm Disruption in the Critically Ill: An 
Opportunity for Improving Outcomes. Crit Care Med. 2016;44:207-217. 
64. Beauchemin KM, Hays P. Dying in the dark: sunshine, gender and outcomes in 
myocardial infarction. J R Soc Med. 1998;91:352-354. 
65. Van Rompaey B, Elseviers MM, Schuurmans MJ, Shortridge-Baggett LM, Truijen S, 
Bossaert L. Risk factors for delirium in intensive care patients: a prospective cohort 
study. Crit Care. 2009;13:R77. 
66. Keep P, James J, Inman M. Windows in the intensive therapy unit. Anaesthesia. 
1980;35:257-262. 
67. Skene DJ. Optimization of light and melatonin to phase-shift human circadian rhythms. 
J Neuroendocrinol. 2003;15:438-441. 
68. Perras B, Meier M, Dodt C. Light and darkness fail to regulate melatonin release in 
critically ill humans. Intensive Care Med. 2007;33:1954-1958. 
69. Hatori M, Vollmers C, Zarrinpar A et al. Time-restricted feeding without reducing 
caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. 
2012;15:848-860. 
70. Tahara Y, Shibata S. Circadian rhythms of liver physiology and disease: experimental 
and clinical evidence. Nat Rev Gastroenterol Hepatol. 2016;13:217-226. 
71. Sultan SS. Assessment of role of perioperative melatonin in prevention and treatment of 
postoperative delirium after hip arthroplasty under spinal anesthesia in the elderly. 
Saudi J Anaesth. 2010;4:169-173. 
72. Al-Aama T, Brymer C, Gutmanis I, Woolmore-Goodwin SM, Esbaugh J, Dasgupta M. 
Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. 
Int J Geriatr Psychiatry. 2011;26:687-694. 
73. de Jonghe A, van Munster BC, Goslings JC et al. Effect of melatonin on incidence of 
delirium among patients with hip fracture: a multicentre, double-blind randomized 
controlled trial. CMAJ. 2014;186:E547-56. 
74. Tekbas OF, Ogur R, Korkmaz A, Kilic A, Reiter RJ. Melatonin as an antibiotic: new 
insights into the actions of this ubiquitous molecule. J Pineal Res. 2008;44:222-226. 
75. Manchester LC, Coto-Montes A, Boga JA et al. Melatonin: an ancient molecule that 
makes oxygen metabolically tolerable. J Pineal Res. 2015;59:403-419. 
76. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. 
Dig Dis Sci. 2002;47:2336-2348. 
77. Lim AS, Chang AM, Shulman JM et al. A common polymorphism near PER1 and the 
timing of human behavioral rhythms. Ann Neurol. 2012;72:324-334. 
78. Cancer and rhythm. [editorial]. Cancer Causes Control 2006;17(4):483. 
79. Madrid-Navarro CJ, Sanchez-Galvez R, Martinez-Nicolas A et al. Disruption of 
Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. 
Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin 
Therapy in an ICU Environment. Curr Pharm Des. 2015;21:3453-3468. 
80. Editorial: Health Impact and Management of a Disrupted Circadian Rhythm and Sleep 
in Critical Illnesses. [editorial]. Curr Pharm Des 2015;21(24):3428. 
 
 
 
 
 
 
 
